Thoracic Neoplasms

Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors

Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection

A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

Erector Spinae Block for Thoracic Surgery

Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients

Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study

Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC

Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy

Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer

Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer

PALACE: Cemiplimab Trial According to ctDNA Levels

Real World Registry for Use of the Ion Endoluminal System

Improving Cancer On-treatment Symptom Management

SPSIPB vs SAPB for Thoracoscopic Surgery

Pain Control After VATS Anatomical Pulmonary Resections

Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Early Intervention Strategies for Lung Cancer

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients